AI — India
IT services reinvention + GPU-compute + data-centre buildout.
The thesis
India doesn't have a pure-play listed AI company — the theme is really (a) large IT services cos retooling for AI-augmented delivery (TCS, Infy, Wipro, HCL, LTIMindtree), (b) data-centre REITs + real-estate plays (Equinix isn't listed in India, but Brookfield India REIT and Embassy REIT benefit), and (c) GPU-compute arbitrage via Yotta, NxtGen (unlisted). The listed proxies are mid-cap IT and select hyperscalers' partners.
Listed constituents
The textbook names with pure-play or meaningful exposure. Not a weighted index — sort by market-cap on /scanner.
| Symbol | Company | Role |
|---|---|---|
| TCS | Tata Consultancy Services | AI-augmented IT services scale |
| INFY | Infosys | AI + cloud transformation |
| WIPRO | Wipro | AI + cloud services |
| HCLTECH | HCL Technologies | Enterprise AI + ER&D |
| LTIM | LTIMindtree | Digital + cloud + AI |
| PERSISTENT | Persistent Systems | Focused digital + AI services |
| COFORGE | Coforge | BFSI + insurance AI delivery |
| KPITTECH | KPIT Technologies | Automotive AI/software |
| EMBASSY | Embassy Office Parks REIT | Data-centre + office REIT |
Tailwinds
- • Enterprise AI spend ramp (Gartner: ~$200bn global by FY27)
- • India data-centre capacity doubling by FY27 (NDCI)
- • GenAI offsetting services-pricing pressure via productivity uplift
- • Indian hyperscaler contract wins (Microsoft, Google, Meta India builds)
Risks
- • Services-pricing compression from AI-productivity gains (double-edged)
- • US H-1B/visa restrictions tightening
- • Valuation reset risk if AI capex slowdown arrives
- • Limited pure-play listed exposure — most India AI innovation is private
Stress-test the narrative
Use these tools on the constituents above to sanity-check the thesis before you size exposure.
Want a deeper dive on AI — India?
Axel can rank these constituents by valuation, sentiment, and 1-year forward estimates — and explain why each name is up or down today.
Primary sources
Other themes
Research tool · not investment advice.
Axel Markets is an information + analytics product. We are not a SEBI-registered Research Analyst (RA) or Investment Adviser (IA). Nothing on this page is a buy, sell, or hold recommendation. Past performance is not indicative of future returns. Verify all data against the authoritative source (NSE, BSE, AMFI, SEBI, company RHP / factsheet) before acting. Theme snapshot as of 2026-04. Constituent weights shift; cross-check live index composition before sizing. Tailwinds + risks are editorial summaries of publicly reported trends, not forecasts. Past performance does not predict future returns. Not investment advice.